Executive and expert insights

War stories, unique CEO insight and bold new ideas

EXECUTIVE AND EXPERT INSIGHTS

PhoreMost raises £11m Series A round to progress targets into drug discovery

Key learnings: PhoreMost completed its Series A round in May 2018, with a t...

Read More

Medius Deal Watch May 2018

This month’s top deals are noticeably in the category of acquisitions rathe...

Read More

Five misconceptions about whistleblowing systems put to rest

Would you like to be able to identify risk - whether it be reputational, fi...

Read More

Aparito applies remote patient monitoring tech to dementia diagnosis

Key learnings: Wales-based digital health company Aparito utilises wearable...

Read More

Cognetivity’s AI-driven cognitive test seeks to address dementia diagnosis challenge

Key learnings: Cognetivity Neurosciences was named joint winner in the Inno...

Read More

Grace cooling device marries design and automation to relieve menopausal symptoms

Key learnings: Cooling device, Grace, won the Peri-Menopause Challenge cate...

Read More

Where can data and AI add value in healthcare and life sciences?

Artificial Intelligence (AI) is likely to have a profound impact in the hea...

Read More

New whistleblowing legislation proposed by European Commission

In the wake of various high profile international whistleblowing scandals, ...

Read More

CMS: Addressing life science challenges through sector experience

Key learnings: Law firm CMS advises a wide spectrum of life sciences client...

Read More

Medius Deal Watch April 2018

How the pharmaceutical industry is changing - where has it come from, where...

Read More

Investorview: Driving early-stage investment in UK life sciences

In March 2018, NCL Technology Ventures launched a £50 million fund to help ...

Read More

NMD Pharma to advance neuromuscular disorder therapies with €38m Series A round

Key learnings:

Read More

EQS Group: Leveraging technology for effective regulatory compliance and investor reach

Key learnings: EQS Group’s range of digital services supports companies in ...

Read More

Investorview: Committing to social responsibility in healthcare investment

Swiss venture capital firm MTIP launched its first fund in 2016, achieving ...

Read More

£29m Series B spurs Enterprise Therapeutics’ muco-regulatory therapies forward

Key learnings:

Read More

JAG Shaw Baker: Readying the life sciences sector for GDPR

Key learnings:

Read More

Overcoming commercialisation challenges in advanced therapies

Learn more about the commercialisation of advanced therapies in the upcomin...

Read More

Brexit: Life Sciences - House of Commons Issues Report

On 21 March 2018, the UK House of Commons Health and Social Care Committee ...

Read More

Why whistleblowing should be a boardroom issue in life sciences

On-demand webinar now available New EU-wide whistleblowing regulations have...

Read More

Marks & Clerk: A future-focused approach to intellectual property in life sciences

Key learnings:

Read More

Gill Jennings & Every: Asking the right questions to optimise life sciences IP

Key learnings:

Read More

A spotlight on life sciences option deals  

Key learnings:

Read More

Learn about funding for advanced therapies 

Biotech and Money and Phacilitate are launching a three-part webinar series...

Read More

Webinar Series: Funding, Commercialisation and Market Access for Advanced Therapies

Learn more about the key funding, commercialisation, and market access chal...

Read More

Gallagher: Steering companies through the life sciences risk landscape

Key learnings:

Read More

Surge in UK pharma and biotech patent filings shows investor confidence

In its latest annual report and statistical release, the European Patent Of...

Read More

Brexit developments and their impact on intellectual property

Boult Wade Tennant is pleased to report that on 19 March 2018, the UK and E...

Read More

Zilico’s diagnostic device moves towards Chinese and global markets

Key learnings: UK-based Zilico has entered into a strategic deal with MaxHe...

Read More

Top tips for refining your pitch

The Biotech and Money Investor Perception Survey 2018 found that more than ...

Read More

Covington: Drawing on life science sector depth to tackle complexity

Key learnings: Life science has always been a core focus for international ...

Read More

SurgaColl’s £3.1m Series A investment to drive next phase of growth

Key learnings: SurgaColl announced the completion of a £3.1 million Series ...

Read More

Carmell Therapeutics advances plasma-based products with $4m Series B support

Key learnings: Carmell™ Therapeutics closed its Series B round in June 2017...

Read More

Investor perspective: Sander Slootweg

Looking back at the past year, 2017 has proven to be a pretty successful ye...

Read More

Life sciences IPOs: Five things to consider

After spending all day on Wednesday 7 February at Biotech & Money’s IPO wor...

Read More

Desperately seeking alpha: the quest for value

"VC investor seeking long-term relationship. WLTM small cap, early-stage, o...

Read More

Leveraging larger capital pools in Europe

On 5 February 2018, the 4th annual Biotech and Money/Medtech and Money Worl...

Read More

The growth finance landscape in biotech 

The state of the market While the European venture capital market has faced...

Read More

INFOGRAPHIC: 2018 INVESTOR PERCEPTION SURVEY HIGHLIGHTS

This infographic presents key findings from the 2nd Biotech and Money Inves...

Read More

CRISPR in Europe: patent protection and the importance of robust priority claims 

CRISPR, the revolutionary gene-editing technology, presents huge opportunit...

Read More

STORM Therapeutics leads the way in RNA epigenetics

Key learnings: STORM Therapeutics is developing small molecule inhibitors o...

Read More

Biotech vs medtech: divergence in intellectual property strategy

The landscape of innovation and investment in the healthcare sector has cha...

Read More

Biotech vs medtech: differences in mapping an IP portfolio

IP portfolio management is often overlooked, but is extremely important if ...

Read More

The New Cambrian Era for Biotech Start-ups

Healthcare is the hottest new sector for start-ups when it comes to new tec...

Read More

Anatomy of a…biotech IPO: Q&A with Neil Clark

On Tuesday 6 February 2018, leading life sciences companies will share thei...

Read More

Anatomy of a…private finance raise: Q&A with Martin Frost

On Tuesday 6 February 2018, leading life sciences companies will share thei...

Read More

Anatomy of a…medtech IPO: Q&A with Richard Davies

On Tuesday 6 February 2018, leading life sciences companies will share thei...

Read More

Case update: Loss of priority leads to revocation of key CRISPR patent

In February 2017, Gill Jennings & Every reported on the preliminary opinion...

Read More

Anatomy of a…hybrid business model: Q&A with Darrin Disley

On Tuesday 6 February 2018, leading life sciences companies will share thei...

Read More

Can I patent my biotechnological invention in Europe? 

Significant discoveries and developments in biotechnological research in re...

Read More

Learn how to protect and manage your intellectual property

A strong intellectual property (IP) position can be the deciding factor in ...

Read More

Biotech and medtech seed funding: what lies ahead?

The 4th annual Biotech and Money/Medtech and Money World Congress will offe...

Read More

Stent Tek sees development ramp up following Series A investment

Key learnings: Medical device company Stent Tek successfully closed its Ser...

Read More

Winner’s spotlight: Verona Pharma

Key learnings: Verona Pharma won the Life Science IPO of the Year Award at ...

Read More

Transatlantic investment: barriers and benefits for life sciences

On Monday 5 February 2018, leading investors will come together in London t...

Read More

Investorview: Proactively Bridging The Early Stage Funding Gap

Sinclair Dunlop, Managing Partner at Epidarex Capital Venture capital firm ...

Read More

Boult Wade Tennant: Aligning patent strategy and commercial aims in life sciences

Key learnings: Boult Wade Tennant provides international patent and trade m...

Read More

Investorview: Dr Z Haroon on Julz Co’s recent investments

Julz Co focuses on healthcare investments across the US, Europe, and Asia-P...

Read More

How Newcastle Science Central is helping to alleviate the UK’s skill shortage in big data

Q&A with Professor Paul Watson, Director of the Digital Institute and Profe...

Read More

How IP can support investment and funding in biotech innovations

Isobel Finnie, Partner and UK and European patent attorney within the Chemi...

Read More

Garry Kasparov: Reframing the conversation on AI and big data

Key learnings: On 14 November, former world chess champion, business speake...

Read More

Ali Mortazavi: On genomic data and pivotal moments for RNAi

On 14 November, RNA therapeutics company Silence Therapeutics hosted a pane...

Read More

Dr Annalisa Jenkins: On RNAi, her new chairmanship, and the importance of female role models

In October 2017, RNA therapeutics company Silence Therapeutics appointed Dr...

Read More

Winner’s spotlight: Oxford BioMedica

Key learnings: Oxford BioMedica was named winner in the UK Public Finance R...

Read More

How is investment in life sciences changing?

Where do you see the most opportunity in life sciences? What are your expec...

Read More

An investor’s outlook on the advanced therapies industry

Investment and funding sources are always at the heart of conversations aro...

Read More

Winner’s spotlight: Artios Pharma

Key learnings: Artios Pharma scooped two awards at the Biotech and Money Aw...

Read More

WideCells sets course for synergistic growth

Key learnings: WideCells Group has achieved some significant milestones thi...

Read More

Winner’s spotlight: Carrick Therapeutics

Key learnings: At this year’s Biotech and Money Awards, Carrick Therapeutic...

Read More

Top five biotech developments in the last 10 years and their importance

Biotech is one of the fastest growing industry sectors and, with the pace o...

Read More

Winner’s spotlight: Horizon Discovery's Darrin Disley

Key learnings: Horizon Discovery’s Dr Darrin Disley was voted UK Public Lif...

Read More

Winner’s spotlight: Horizon Discovery

Key learnings: Horizon Discovery was named winner in the Public Life Scienc...

Read More

Jane Griffiths: Pharma's role in the evolving healthcare landscape

Key learnings:  On 13 November 2017, Jane Griffiths, Global Head at Actelio...

Read More

Crowdfunding highlight: combating antimicrobial resistance

Antibiotics have been the miracle treatment for bacterial infections ever s...

Read More

Winner’s spotlight: F-star

Key learnings: F-star won the UK Life Science Deal of the Year Award at the...

Read More

Winner’s spotlight: F-star's John Haurum 

Key learnings: F-star’s John Haurum was named UK Private Life Science CEO o...

Read More

The 4th annual Biotech and Money / Medtech and Money World Congress 2018

The 4th annual Biotech and Money / Medtech and Money World Congress is a hi...

Read More

Winner’s spotlight: Microbiotica

Key learnings: Microbiotica was named winner in the Life Science Spin-Out o...

Read More

GDPR: Practical tips for the life sciences sector

Key learnings: The General Data Protection Regulation (GDPR) will bring abo...

Read More

GDPR: Key changes for life sciences organisations

Key learnings: The General Data Protection Regulation (GDPR) will come into...

Read More

What are the challenges and opportunities facing the healthcare sector?

Key learnings: On 13 November 2017, the life science and investment communi...

Read More

SkinBioTherapeutics on track with post-IPO milestones

Key learnings: SkinBioTherapeutics’ SkinBiotix® technology has passed third...

Read More

Winner’s spotlight: Bicycle Therapeutics

Key learnings: Bicycle Therapeutics was named Life Science Growth Company o...

Read More

What does the future hold for digital health investment?

Key learnings: The Biotech and Money community gathered for Biotechs and th...

Read More

Investor insights: The path to career success in life sciences

Key learnings: VC investors gathered at the Future Investor Forum 2017 to d...

Read More

2017 Biotech and Money Assembly and Awards Gala Dinner

A record number turned out for the annual Biotech and Money Assembly and Aw...

Read More

From Strength to Strength: Unpacking Clinigen's Route to Success

Putting patient care at the heart of its mission, Clinigen’s unique approac...

Read More

[Webinar Recording] The Current State of the M&A Landscape

Are you considering M&A transactions as a potential exit strategy, step to ...

Read More

[Webinar Recording] The Anatomy of a successful IPO

On the 27th June, we spoke to an expert panel to discuss the how, when, wha...

Read More

Will Horizon successfully navigate the path to profit?

Currently one of the most successful life science companies in the country,...

Read More

Management to investors: the communicative conundrum

We have published our annual investor perception survey, confirming or disp...

Read More

All in the Delivery - Interview with Simon Newman, CSO, Ryboquin

Biotech and Money recently talked to Simon Newman, CSO of Ryboquin, about t...

Read More

Interview with Daniel Oliver, CEO of Capital Cell

Daniel Oliver, CEO of Capital Cell, recently took the time to grant us an i...

Read More

Patenting problems specific to the biotech and healthcare sector

This is the fourth and final article in our series that aims to provide tip...

Read More

Nine things we learned from Centauri CEO Mike Westby

Biotech and Money recently talked to Mike Westby, CEO of Centauri, about th...

Read More

Interview with Dr Sara Nunez-Garcia, Principal, Sofinnova Partners

Phacilitate's Investment for Advanced Therapies in partnership with Biotech...

Read More

What are the most important lessons to be learnt from the European immunotherapy and cell & gene therapy industries?

Phacilitate's Investment for Advanced Therapies in partnership with Biotech...

Read More

Bionure breaks the records raising more than 1M€

Highlights Capital Cell’s crowdfunding campaign - Bionure - overfunds with ...

Read More

United Data in the United Kingdom: Congenica Diagnoses a Bright Future for UK Life Science Technologies

Tom Weaver CEO Congenica Using data analytics and applying their software t...

Read More

Open Window in the West? Deciding whether to pursue a US IPO

By Kristian Wiggert Partner Covington & Burling LLP, London The recent stro...

Read More

The impact of other people’s IP on you

This is the third in a series of four articles which aim to provide tips fo...

Read More
View More

Community Partners